73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Trial shows promise for new antibody cancer treatment

Trial shows promise for new antibody cancer treatment

byKing's College LondonMechanism of cytotoxicity mediated by MOv18 IgE. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-39679-9The first ever clinical trial of a new

Trial shows promise for new antibody cancer treatment

byKing's College LondonMechanism of cytotoxicity mediated by MOv18 IgE. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-39679-9The first ever clinical trial of a new
Results of trial will help guide treatment of malignant bowel obstruction in patients with advanced cancer

Results of trial will help guide treatment of malignant bowel obstruction in patients with advanced cancer

by SWOG Cancer Research NetworkCredit: CC0 Public DomainFindings from the first-ever prospective trial including a randomized pathway comparing surgery to non-surgical treatment of malignant bowel obs

Results of trial will help guide treatment of malignant bowel obstruction in patients with advanced cancer

by SWOG Cancer Research NetworkCredit: CC0 Public DomainFindings from the first-ever prospective trial including a randomized pathway comparing surgery to non-surgical treatment of malignant bowel obs
Discovery could lead to 'kinder' treatment for childhood neuroblastoma

Discovery could lead to 'kinder' treatment for childhood neuroblastoma

by University of CambridgeA ball of neuroblastoma cells forming mature nerves after drug treatment. Credit: Kirsty Ferguson/Developmental CellChildren with neuroblastoma—responsible for 15% of ca

Discovery could lead to 'kinder' treatment for childhood neuroblastoma

by University of CambridgeA ball of neuroblastoma cells forming mature nerves after drug treatment. Credit: Kirsty Ferguson/Developmental CellChildren with neuroblastoma—responsible for 15% of ca
Breast cancer awareness campaigns too often overlook those with metastatic breast cancer. Here's how they can do better

Breast cancer awareness campaigns too often overlook those with metastatic breast cancer. Here's how they can do better

by Rachel Kraus,The ConversationCredit: Unsplash/CC0 Public DomainIs there anyone who isn't aware of breast cancer?Since 1985, cancer-related nonprofits, along with pharmaceutical firms and

Breast cancer awareness campaigns too often overlook those with metastatic breast cancer. Here's how they can do better

by Rachel Kraus,The ConversationCredit: Unsplash/CC0 Public DomainIs there anyone who isn't aware of breast cancer?Since 1985, cancer-related nonprofits, along with pharmaceutical firms and
Study examines treatment options for women with recurrent ovarian cancer

Study examines treatment options for women with recurrent ovarian cancer

by WileyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) and mucinous epit

Study examines treatment options for women with recurrent ovarian cancer

by WileyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) and mucinous epit
A HER2-targeting peptide drug conjugate with better penetrability for effective breast cancer therapy

A HER2-targeting peptide drug conjugate with better penetrability for effective breast cancer therapy

by Compuscript LtdSchematic diagram and pharmacokinetics of HER2-TP-cy5.5 and HER-TA-cy5.5 conjugate synthesis. (A) Schematic representation of the utilization of HER2-targeting peptide/antibody and C

A HER2-targeting peptide drug conjugate with better penetrability for effective breast cancer therapy

by Compuscript LtdSchematic diagram and pharmacokinetics of HER2-TP-cy5.5 and HER-TA-cy5.5 conjugate synthesis. (A) Schematic representation of the utilization of HER2-targeting peptide/antibody and C
Study highlights difficulty in diagnosing blood disorders, need for coordination between clinicians and pathologists

Study highlights difficulty in diagnosing blood disorders, need for coordination between clinicians and pathologists

by University of Miami Leonard M. Miller School of Medicine“Our findings highlight the vital importance of seeking expert opinions from National Cancer Institute-designated cancer centers, especi

Study highlights difficulty in diagnosing blood disorders, need for coordination between clinicians and pathologists

by University of Miami Leonard M. Miller School of Medicine“Our findings highlight the vital importance of seeking expert opinions from National Cancer Institute-designated cancer centers, especi
Finding new ways to treat diffuse midline gliomas

Finding new ways to treat diffuse midline gliomas

by Greg Glasgow,CU Anschutz Medical CampusPlanning CTs demonstrating positioning of the mouse on the custom platform and RT fields for the two RT groups, along with the RT schedule for both grou

Finding new ways to treat diffuse midline gliomas

by Greg Glasgow,CU Anschutz Medical CampusPlanning CTs demonstrating positioning of the mouse on the custom platform and RT fields for the two RT groups, along with the RT schedule for both grou
Preventing 'chemo brain' with antioxidants targeting the spinal fluid

Preventing 'chemo brain' with antioxidants targeting the spinal fluid

by Children's Hospital BostonGraphical abstract. Credit:Neuron(2022). DOI: 10.1016/j.neuron.2022.08.009Up to three quarters of patients receiving cancer chemotherapy suffer from &

Preventing 'chemo brain' with antioxidants targeting the spinal fluid

by Children's Hospital BostonGraphical abstract. Credit:Neuron(2022). DOI: 10.1016/j.neuron.2022.08.009Up to three quarters of patients receiving cancer chemotherapy suffer from &
Estrogen-negative cancers respond to anti-estrogenic therapies, study shows

Estrogen-negative cancers respond to anti-estrogenic therapies, study shows

byHokkaido UniversityCredit: Nabeel KajiharaAnti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor t

Estrogen-negative cancers respond to anti-estrogenic therapies, study shows

byHokkaido UniversityCredit: Nabeel KajiharaAnti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor t
Research shows that DOPA protects against melanoma

Research shows that DOPA protects against melanoma

byPerelman School of Medicine at the University of PennsylvaniaHistologic characterization of representative orthotopic skin and resulting tumors, including MC and proliferation markers MITF (re

Research shows that DOPA protects against melanoma

byPerelman School of Medicine at the University of PennsylvaniaHistologic characterization of representative orthotopic skin and resulting tumors, including MC and proliferation markers MITF (re
Efficacy shown for new melanoma therapeutic vaccine

Efficacy shown for new melanoma therapeutic vaccine

by Physician's Briefing StaffIn a recent trial, a new melanoma vaccine, mRNA-4157 (V940), when taken in combination with Keytruda (pembrolizumab), was found to be effective in battling the deadly

Efficacy shown for new melanoma therapeutic vaccine

by Physician's Briefing StaffIn a recent trial, a new melanoma vaccine, mRNA-4157 (V940), when taken in combination with Keytruda (pembrolizumab), was found to be effective in battling the deadly